National Association of Testing Authorities, Australia
Scope of Accreditation
Saturn Pathology Pty Ltd
Scope of Accreditation
Stirling Laboratory
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Service | Product | Determinant |
---|---|---|
Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Activated partial thromboplastin time (APTT); Fibrinogen; International normalised ratio (INR); Prothrombin time (PT); Thrombin time (TT) |
Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Service | Product | Determinant |
---|---|---|
Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Serum | Vancomycin |
Chemical pathology - Detection and/or quantitation of tumour markers | Plasma; Serum | CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); α-Fetoprotein (AFP) |
Serum | Prostate specific antigen (PSA); Prostate specific antigen (PSA) - Free | |
Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma; Serum | C-peptide; Insulin |
Cortisol; Follicle stimulating hormone (FSH); Luteinising hormone (LH); Oestradiol; Parathyroid hormone (PTH); Progesterone; Testosterone; Testosterone - Free; Testosterone - Total | ||
Sex hormone binding globulin (SHBG) | ||
Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Chemical pathology - Further investigation of cardiac function | Serum | N-Terminal-pro b-type natriuretic peptide (NT-proBNP) |
Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | Calcium; Magnesium; Phosphate |
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Aspartate aminotransferase; Bilirubin - Direct; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Carbon dioxide (CO2); Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; HDL - Quantitation; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase |
Urine | Calcium - Total; Chloride; Creatinine; Magnesium; Microalbumin; Phosphate; Potassium; Protein - Total; Sodium | |
Chemical pathology - Investigation for folate deficiency | Serum | Folate |
Chemical pathology - Iron studies | Plasma; Serum | Ferritin; Iron; Transferrin; Transferrin - Iron saturation percentage (%) |
Chemical pathology - Markers of bone metabolism | Serum | β-Crosslaps (CTX) |
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Serum | Calcium - Ionised; pH |
Chemical pathology - Quantitation of vitamin B markers | Plasma; Serum | Holotranscobalamin (active vitamin B12) |
Chemical pathology - Quantitation of vitamins | Plasma; Serum | Cobalamin (vitamin B12); Vitamin D |
Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
Haematology - Full blood examination | Blood | Morphology |
Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes | ||
Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO) |
Serum | Anti-deamidated gliadin peptide (DGP) antibodies; Anti-double stranded DNA antibodies (dsDNA); Anti-extractable nuclear antigen antibodies (ENA); Anti-tissue transglutaminase antibodies (tTG) | |
Rheumatoid factor | ||
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Animal mix; Cat dander; Dog dander |
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Egg white |
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Milk |
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) | Serum | Staple food mix |
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Wheat |
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Grass mix; Rye grass |
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Mould mix |
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | House dust mite mix |
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Tree mix |
Immunopathology - Quantitation of complement proteins | Plasma; Serum | Complement components C3 and C4 |
Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin E |
Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M | ||
Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
20772
Site No.
24928
Print date
10 Oct 2024
END OF SCOPE